Extracellular Vesicle Biogenesis Modulation
Quality Report Card click to collapse
From Analysis:
Tau propagation mechanisms and therapeutic interception points
Investigate prion-like spreading of tau pathology through connected brain regions, focusing on trans-synaptic transfer, extracellular vesicle-mediated spread, and intervention strategies at each propagation step
Hypotheses from Same Analysis (6)
These hypotheses emerged from the same multi-agent debate that produced this hypothesis.
Description
Molecular Mechanism and Rationale
The endosomal sorting complex required for transport III (ESCRT-III) represents a critical molecular machinery governing the final stages of extracellular vesicle (EV) biogenesis, particularly the formation of multivesicular bodies (MVBs) and subsequent exosome release. CHMP4B (Charged Multivesicular body Protein 4B) functions as a core component of the ESCRT-III complex, working in concert with other CHMP proteins (CHMP2A, CHMP3, CHMP6) to execute membrane scission events during intraluminal vesicle (ILV) formation within MVBs. The VPS4 ATPase complex, comprising VPS4A and VPS4B subunits, provides the energy required for ESCRT-III disassembly and recycling following membrane abscission.
Curated Mechanism Pathway
Curated pathway diagram from expert analysis
graph TD
A["Pathological tau<br/>hyperphosphorylation<br/>(Ser202/Thr205, Thr231)"]
B["Ubiquitinated tau<br/>species"]
C["ESCRT-0 complex<br/>(HRS recognition)"]
D["Early endosome<br/>formation"]
E["ESCRT-I/II<br/>recruitment"]
F["CHMP4B<br/>(ESCRT-III core)"]
G["CHMP2A/CHMP3/CHMP6<br/>co-assembly"]
H["Membrane scission<br/>and ILV formation"]
I["VPS4A/VPS4B<br/>ATPase complex"]
J["ESCRT-III<br/>disassembly"]
K["MVB maturation"]
L["Exosome release<br/>with tau cargo"]
M["Extracellular tau<br/>propagation"]
N["Neurodegeneration<br/>progression"]
O["CHMP4B modulation<br/>therapeutic target"]
A -->|"phosphorylation events"| B
B -->|"substrate recognition"| C
C -->|"endosomal sorting"| D
D -->|"machinery recruitment"| E
E -->|"ESCRT-III activation"| F
F -->|"complex assembly"| G
G -->|"membrane remodeling"| H
H -->|"energy requirement"| I
I -->|"ATP hydrolysis"| J
J -->|"vesicle maturation"| K
K -->|"cargo release"| L
L -->|"intercellular transfer"| M
M -->|"pathology spread"| N
O -->|"therapeutic intervention"| F
classDef normal fill:#4fc3f7
classDef therapeutic fill:#81c784
classDef pathology fill:#ef5350
classDef outcome fill:#ffd54f
classDef molecular fill:#ce93d8
class D,E,G,H,I,J,K normal
class O therapeutic
class A,B,M,N pathology
class L outcome
class C,F molecular
3D Protein Structure
Interactive 3D viewer powered by RCSB PDB / Mol*. Use mouse to rotate, scroll to zoom.
Dimension Scores
Legacy Card View — expandable citation cards
✓ Supporting Evidence 10
The intraluminal vesicles (ILVs) of endosomes mediate the delivery of activated signaling receptors and other proteins to lysosomes for degradation, but they also modulate intercellular communication when secreted as exosomes. The formation of ILVs requires four complexes, ESCRT-0, -I, -II, and -III, with ESCRT-0, -I, and -II presumably involved in cargo sorting and ESCRT-III in membrane deformation and fission. Here, we report that an active form of the ESCRT-associated protein ALIX efficiently recruits ESCRT-III proteins to endosomes. This recruitment occurs independently of other ESCRTs but requires lysobisphosphatidic acid (LBPA) in vivo, and can be reconstituted on supported bilayers in vitro. Our data indicate that this ALIX- and ESCRT-III-dependent pathway promotes the sorting and delivery of tetraspanins to exosomes. We conclude that ALIX provides an additional pathway of ILV formation, secondary to the canonical pathway, and that this pathway controls the targeting of exosomal
The endosomal sorting complex required for transport (ESCRT) machinery plays a key role in the repair of damaged plasma membranes with puncta form and removes pores from the plasma membrane in regulated cell death, apoptosis, necroptosis, pyroptosis, ferroptosis, and autophagy. ESCRT-I overexpression and ESCRT-III-associated charged multivesicular body protein (CHMP) 4B participate in apoptosis, and the ESCRT-1 protein TSG 101 maintains low levels of ALIX and ALG-2 and prevents predisposition to apoptosis. The ESCRT-III components CHMP2A and CHMP4B are recruited to broken membrane bubble sites with the requirement of extracellular Ca2+, remove membrane vesicles from cells, and delay the time required for active MLKL to mediate necroptosis, thus preserving cell survival. CHMP4B disturbed pyroptosis by recruiting around the plasma membrane neck to remove the GSDMD pores and preserve plasma membrane integrity depending on Ca2+ influx. The accumulation of the ESCRT-III subunits CHMP5 and C
Classical swine fever virus (CSFV) incurs substantial economic losses in the global swine industry due to its persistent emergence and re-emergence across various countries. However, the precise mechanisms governing CSFV budding remain inadequately understood. Our study elucidates that the endosomal sorting complex required for transport (ESCRT)-associated protein ALIX, in conjunction with ESCRT-III, plays a pivotal role in orchestrating CSFV budding. Genomic sequence analysis identified a critical interaction between the YPXnL late domain on the E2 protein and ALIX. Through immunoprecipitation and structural domain deletion assays, we demonstrated that the ALIX Bro1 domain specifically recognized viral particles by binding to the YPXnL motif. Immunoelectron and transmission electron microscopy further confirmed that, upon infection, ALIX accumulated at the periphery of subcellular organelles, including COPII vesicles, endosomes, and the Golgi apparatus, thereby facilitating CSFV buddi
Cellular abscission is the final step of cytokinesis that leads to the physical separation of the two daughter cells. The scaffold protein ALIX and the ESCRT-I protein TSG101 contribute to recruiting ESCRT-III to the midbody, which orchestrates the final membrane scission of the intercellular bridge. Here, we addressed the transport mechanisms of ALIX and ESCRT-III subunit CHMP4B to the midbody. Structured illumination microscopy revealed gradual accumulation of ALIX at the midbody, resulting in the formation of spiral-like structures extending from the midbody to the abscission site, which strongly co-localized with CHMP4B. Live-cell microscopy uncovered that ALIX appeared together with CHMP4B in vesicular structures, whose motility was microtubule-dependent. Depletion of ALIX led to structural alterations of the midbody and delayed recruitment of CHMP4B, resulting in delayed abscission. Likewise, depletion of the kinesin-1 motor KIF5B reduced the motility of ALIX-positive vesicles an
Inactivation of the endosomal sorting complex required for transport (ESCRT) machinery has been reported to cause autophagic defects, but the exact functions of ESCRT proteins in macroautophagy/autophagy remain incompletely understood. Using live-cell fluorescence microscopy we found that the filament-forming ESCRT-III subunit CHMP4B was recruited transiently to nascent autophagosomes during starvation-induced autophagy and mitophagy, with residence times of about 1 and 2 min, respectively. Correlative light microscopy and electron tomography revealed CHMP4B recruitment at a late step in mitophagosome formation. The autophagosomal dwell time of CHMP4B was strongly increased by depletion of the regulatory ESCRT-III subunit CHMP2A. Using a novel optogenetic closure assay we observed that depletion of CHMP2A inhibited phagophore sealing during mitophagy. Consistent with this, depletion of CHMP2A and other ESCRT-III subunits inhibited both PRKN/PARKIN-dependent and -independent mitophagy.
Pyroptosis drives tumor progression and immune evasion in Hepatocellular Carcinoma: a single-cell and spatial … MEDIUM▼
BACKGROUND: Pyroptosis is a form of programmed cell death characterized by inflammasome activation and the release of inflammatory cytokines, which induce a strong immune response. Unlike apoptosis, pyroptosis can elicit potent immune stimulation, potentially playing a crucial role in anti-tumor immunity. However, it may also promote tumor progression by altering the tumor microenvironment and facilitating immune evasion. This study investigates pyroptosis-related gene expression in hepatocellular carcinoma (HCC), with a focus on identifying key genes that influence prognosis and tumor microenvironment dynamics. METHODS: Single-cell RNA sequencing (scRNA-seq) data from 10 HCC patients were obtained from the GEO database (GSE149614), along with spatial transcriptomic data and bulk RNA-seq data from TCGA. We performed data processing and quality control using the Seurat package and applied machine learning techniques, including LASSO regression, to identify key pyroptosis-related genes.
CHMP4B is a core ESCRT-III component that oligomerizes to form membrane-remodeling filaments essential for ext… DIRECT▼
Cancer cells acquire distinct metabolic adaptations to survive stress associated with tumour growth and to satisfy the anabolic demands of proliferation. The tumour suppressor protein p53 (also known as TP53) influences a range of cellular metabolic processes, including glycolysis, oxidative phosphorylation, glutaminolysis and anti-oxidant response. In contrast to its role in promoting apoptosis during DNA-damaging stress, p53 can promote cell survival during metabolic stress, a function that may contribute not only to tumour suppression but also to non-cancer-associated functions of p53. Here we show that human cancer cells rapidly use exogenous serine and that serine deprivation triggered activation of the serine synthesis pathway and rapidly suppressed aerobic glycolysis, resulting in an increased flux to the tricarboxylic acid cycle. Transient p53-p21 (also known as CDKN1A) activation and cell-cycle arrest promoted cell survival by efficiently channelling depleted serine stores to
CHMP4B knockdown reduces exosome biogenesis and impairs tetraspanin sorting to extracellular vesicles through … DIRECT▼
Evolutionary innovations are dependent on mutations. Mutation rates are increased by adverse conditions in the laboratory, but there is no evidence that stressful environments that do not directly impact on DNA leave a mutational imprint on extant genomes. Mutational spectra in the laboratory are normally determined with unstressed cells but are unavailable with stressed bacteria. To by-pass problems with viability, selection effects, and growth rate differences due to stressful environments, in this study we used a set of genetically engineered strains to identify the mutational spectrum associated with nutritional stress. The strain set members each had a fixed level of the master regulator protein, RpoS, which controls the general stress response of Escherichia coli. By assessing mutations in cycA gene from 485 cycloserine resistant mutants collected from as many independent cultures with three distinct perceived stress (RpoS) levels, we were able establish a dose-dependent relation
CHMP4B interacts with ALIX at multivesicular body membranes to regulate both exosome release and cytokinetic a… DIRECT▼
Cytochrome P450 3A4, a major drug-metabolizing enzyme in man, is well known to show non-Michaelis-Menten steady-state kinetics for a number of substrates, indicating that more than one substrate can bind to the enzyme simultaneously, but it has proved difficult to obtain reliable estimates of exactly how many substrate molecules can bind. We have used a simple method involving studies of the effect of large inhibitors on the Hill coefficient to provide improved estimates of substrate stoichiometry from simple steady-state kinetics. Using a panel of eight inhibitors, we show that at least four molecules of the widely used CYP3A4 substrate 7-benzyloxyquinoline can bind simultaneously to the enzyme. Computational docking studies show that this is consistent with the recently reported crystal structures of the enzyme. In the case of midazolam, which shows simple Michaelis-Menten kinetics, the inhibitor effects demonstrate that two molecules must bind simultaneously, consistent with earlier
Modulation of CHMP4B expression alters extracellular vesicle cargo loading and release rates, affecting interc… MECHANISTIC▼
BACKGROUND: During the last decades data from different studies reported modifications of the topographic distribution of colorectal cancers (CRCs), with an increased frequency of tumours in proximal colonic segments. Given the documented link between adenomas and CRC, a proximal migration of adenomas over time could be expected as well. AIM: To evaluate available evidence about the prevalence of adenomas and of sessile serrated polyps across colonic segments, the changing trends in their distribution across the colon and the diagnostic performance of screening tests currently adopted in population based screening programs for lesions located in different colonic segments. METHODS: Literature search on PubMed, Embase, and Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects with reference to preferred reporting items for systematic reviews and meta-analysis (PRISMA), considering all adult human studies in English, published between January 2000 and Febru
✗ Opposing Evidence 5
Autophagy is a regulated pathway for bulk degradation of cytoplasmic contents and organelles, an important process involved in many physiological and pathological conditions in multiple organs, including the nervous system. It has been proposed that developing autophagosomes fuse with late endosomal compartments before their fusion with lysosomes; however, little is known about the functional relationship between the autophagy and endocytic pathways. In the endosomal-lysosomal pathway, a key step in sorting transmembrane cargo proteins is regulated by multimeric complexes called ESCRT (endosomal sorting complex required for transport). We recently reported that dysfunction of ESCRT-III, either by depletion of its essential subunit mSnf7-2 or by expression of a mutant CHMP2B protein associated with frontotemporal dementia linked to chromosome 3 (FTD3), caused autophagosome accumulation and dendritic retraction before neurodegeneration in cultured mature cortical neurons. This defect is
BACKGROUND: Adeno-associated virus (AAV) has emerged as one of the best tools for cardiac gene delivery due to its cardiotropism, long-term expression, and safety. However, a significant challenge to its successful clinical use is preexisting neutralizing antibodies (NAbs), which bind to free AAVs, prevent efficient gene transduction, and reduce or negate therapeutic effects. Here we describe extracellular vesicle-encapsulated AAVs (EV-AAVs), secreted naturally by AAV-producing cells, as a superior cardiac gene delivery vector that delivers more genes and offers higher NAb resistance. METHODS: We developed a 2-step density-gradient ultracentrifugation method to isolate highly purified EV-AAVs. We compared the gene delivery and therapeutic efficacy of EV-AAVs with an equal titer of free AAVs in the presence of NAbs, both in vitro and in vivo. In addition, we investigated the mechanism of EV-AAV uptake in human left ventricular and human induced pluripotent stem cell-derived cardiomyocyt
Therapeutic potential and mechanisms of mesenchymal stem cell-derived exosomes as bioactive materials in tendo… MEDIUM▼
Tendon-bone insertion (TBI) injuries, such as anterior cruciate ligament injury and rotator cuff injury, are the most common soft tissue injuries. In most situations, surgical tendon/ligament reconstruction is necessary for treating such injuries. However, a significant number of cases failed because healing of the enthesis occurs through scar tissue formation rather than the regeneration of transitional tissue. In recent years, the therapeutic potential of mesenchymal stem cells (MSCs) has been well documented in animal and clinical studies, such as chronic paraplegia, non-ischemic heart failure, and osteoarthritis of the knee. MSCs are multipotent stem cells, which have self-renewability and the ability to differentiate into a wide variety of cells such as chondrocytes, osteoblasts, and adipocytes. Numerous studies have suggested that MSCs could promote angiogenesis and cell proliferation, reduce inflammation, and produce a large number of bioactive molecules involved in the repair.
CHMP4B depletion does not significantly alter exosome release rates in mammalian cells, suggesting CHMP4B is r… STRONG▼
Although clinical studies show that childhood asthma can be controlled well with inhaled corticosteroids, many children with asthma remain symptomatic despite maintenance treatment with inhaled corticosteroids. In this article, we present 10 tips for successfully treating childhood asthma using only an inhaled corticosteroid and a short-acting bronchodilator. These 10 tips are: make the diagnosis based on the history; do not emphasize the role of lung function studies in the diagnostic process; treat asthma with appropriate medications once you have made the diagnosis; collaborate with the patient and his or her parents; pay attention to the non-drug aspects of therapy; choose an inhaler the child is able to use, train correct use; make follow-up appointments; monitor symptoms, exacerbations and impact on daily life; when children remain symptomatic despite the use of inhaled steroids: investigate potential causes; invest in mutual collaboration between primary and secondary care.
CHMP4B primarily functions in cytokinetic abscission rather than extracellular vesicle production, with minima… MODERATE-STRONG▼
Acid-sensing ion channels (ASICs) are cationic channels activated by extracellular acidosis that are expressed in both central and peripheral nervous systems. Although peripheral ASICs seem to be natural sensors of acidic pain (e.g., in inflammation, ischaemia, lesions or tumours), a direct demonstration is still lacking. We show that approximately 60% of rat cutaneous sensory neurons express ASIC3-like currents. Native as well as recombinant ASIC3 respond synergistically to three different inflammatory signals that are slight acidifications (approximately pH 7.0), hypertonicity and arachidonic acid (AA). Moderate pH, alone or in combination with hypertonicity and AA, increases nociceptors excitability and produces pain suppressed by the toxin APETx2, a specific blocker of ASIC3. Both APETx2 and the in vivo knockdown of ASIC3 with a specific siRNA also have potent analgesic effects against primary inflammation-induced hyperalgesia in rat. Peripheral ASIC3 channels are thus essential se
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses ▼
🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns ▼
Skeptic's Critical Evaluation Framework
Acknowlegment of Role
I'm ready to evaluate the hypotheses. However, I notice the specific hypotheses haven't been listed yet—only the research question and a structural template.
I'll proceed on the assumption the hypotheses concern:
If these don't match your Theorist's actual claims
🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation ▼
Domain Expert Response: Translating Tau Spreading Hypotheses to Clinical Impact
Preamble: Where We Stand Today
The therapeutic landscape for Alzheimer's offers a sobering context: three amyloid-targeting antibodies have received accelerated/traditional approval since 2021, yet none have demonstrated robust cognitive preservation in isolation. This changes the calculus for tau-targeting strategies. The question is no longer whether to target tau, but where in the pathological cascade gives the best risk-benefit ratio for intervention. The hypotheses you've proposed sit at that
⚖ Synthesizer Integrates perspectives and produces final ranked assessments ▼
Price History
| Event | Price | Change | Source | Time | |
|---|---|---|---|---|---|
| 📄 | New Evidence | $0.374 | ▲ 3.1% | evidence_batch_update | 2026-04-13 02:18 |
| 📄 | New Evidence | $0.362 | ▲ 6.5% | evidence_batch_update | 2026-04-13 02:18 |
| ⚖ | Recalibrated | $0.340 | ▼ 0.5% | 2026-04-12 07:19 | |
| ⚖ | Recalibrated | $0.342 | ▼ 2.2% | 2026-04-10 15:58 | |
| ⚖ | Recalibrated | $0.349 | ▲ 2.5% | 2026-04-10 15:53 | |
| ⚖ | Recalibrated | $0.341 | ▼ 0.3% | 2026-04-08 22:18 | |
| ⚖ | Recalibrated | $0.342 | ▼ 3.2% | 2026-04-08 18:39 | |
| 📄 | New Evidence | $0.353 | ▲ 4.3% | evidence_batch_update | 2026-04-04 09:08 |
| ⚖ | Recalibrated | $0.339 | ▼ 2.1% | 2026-04-03 23:46 | |
| ⚖ | Recalibrated | $0.346 | ▲ 1.4% | 2026-04-02 21:55 | |
| ⚖ | Recalibrated | $0.341 | ▼ 9.8% | market_recalibrate | 2026-04-02 19:14 |
| 📄 | New Evidence | $0.378 | ▼ 34.1% | market_dynamics | 2026-04-02 17:18 |
| 💬 | Debate Round | $0.573 | ▲ 3.1% | debate_engine | 2026-04-02 12:58 |
| 📄 | New Evidence | $0.556 | ▲ 63.5% | evidence_update | 2026-04-02 10:59 |
| ⚖ | Recalibrated | $0.340 | ▼ 37.6% | 2026-04-02 09:49 |
Clinical Trials (3) Relevance: 37%
Active
Completed
Total Enrolled
Highest Phase
📚 Cited Papers (30)
📓 Linked Notebooks (1)
Wiki Pages
KG Entities (45)
Related Hypotheses
Estimated Development
🧪 Falsifiable Predictions
Knowledge Subgraph (100 edges)
associated with (8)
co associated with (22)
implicated in (4)
involved in (1)
participates in (5)
regulates (14)
therapeutic target (7)
Mechanism Pathway for CHMP4B
Molecular pathway showing key causal relationships underlying this hypothesis
graph TD
CHMP4B["CHMP4B"] -->|regulates| Extracellular_Vesicle_Bio["Extracellular Vesicle Biogenesis Modulation"]
CHMP4B_1["CHMP4B"] -->|regulates| Tau_Propagation["Tau Propagation"]
CHMP4B_2["CHMP4B"] -->|associated with| neurodegeneration["neurodegeneration"]
CHMP4B_3["CHMP4B"] -->|implicated in| neurodegeneration_4["neurodegeneration"]
CHMP4B_5["CHMP4B"] -->|co associated with| SNAP25["SNAP25"]
CHMP4B_6["CHMP4B"] -->|co associated with| TREM2["TREM2"]
CHMP4B_7["CHMP4B"] -->|co associated with| NLGN1["NLGN1"]
CHMP4B_8["CHMP4B"] -->|co associated with| HSP90AA1["HSP90AA1"]
CHMP4B_9["CHMP4B"] -->|co associated with| LRP1["LRP1"]
CHMP4B_10["CHMP4B"] -->|co associated with| VCP["VCP"]
CHMP4B_11["CHMP4B"] -->|participates in| Endosomal_sorting___vesic["Endosomal sorting / vesicle trafficking"]
CHMP4B_12["CHMP4B"] -->|associated with| Alzheimer_s_Disease["Alzheimer's Disease"]
style CHMP4B fill:#ce93d8,stroke:#333,color:#000
style Extracellular_Vesicle_Bio fill:#4fc3f7,stroke:#333,color:#000
style CHMP4B_1 fill:#ce93d8,stroke:#333,color:#000
style Tau_Propagation fill:#ffd54f,stroke:#333,color:#000
style CHMP4B_2 fill:#ce93d8,stroke:#333,color:#000
style neurodegeneration fill:#ef5350,stroke:#333,color:#000
style CHMP4B_3 fill:#ce93d8,stroke:#333,color:#000
style neurodegeneration_4 fill:#ef5350,stroke:#333,color:#000
style CHMP4B_5 fill:#ce93d8,stroke:#333,color:#000
style SNAP25 fill:#ce93d8,stroke:#333,color:#000
style CHMP4B_6 fill:#ce93d8,stroke:#333,color:#000
style TREM2 fill:#ce93d8,stroke:#333,color:#000
style CHMP4B_7 fill:#ce93d8,stroke:#333,color:#000
style NLGN1 fill:#ce93d8,stroke:#333,color:#000
style CHMP4B_8 fill:#ce93d8,stroke:#333,color:#000
style HSP90AA1 fill:#ce93d8,stroke:#333,color:#000
style CHMP4B_9 fill:#ce93d8,stroke:#333,color:#000
style LRP1 fill:#ce93d8,stroke:#333,color:#000
style CHMP4B_10 fill:#ce93d8,stroke:#333,color:#000
style VCP fill:#ce93d8,stroke:#333,color:#000
style CHMP4B_11 fill:#ce93d8,stroke:#333,color:#000
style Endosomal_sorting___vesic fill:#81c784,stroke:#333,color:#000
style CHMP4B_12 fill:#ce93d8,stroke:#333,color:#000
style Alzheimer_s_Disease fill:#ef5350,stroke:#333,color:#000
3D Protein Structure
🧬 CHMP4B — PDB 4ABM Click to expand 3D viewer
Source Analysis
Tau propagation mechanisms and therapeutic interception points
neurodegeneration | 2026-04-04 | completed